SCHEMBL17008148

SCHEMBL17008148

c1ccc2c(c1)-c1ccccc1C21c2cc(-c3ccc4ccccc4c3)ccc2-c2ccc3cc(-c4ccc5ccccc5c4)ccc3c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.39
HSD17B2 P37059 3/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
GSTP1 P09211 1/20 0.38
ALOX5 P09917 1/20 0.37
PDK2 Q15119 8/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
PIM1 P11309 1/20 0.35
MAOB P27338 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953556 0.87 HSD17B1 (0.38) HSD17B1HSD17B2SLC6A2SLC6A4SLC6A3
SCHEMBL21176145 0.86 CYP1A2 (0.40) HSD17B1HSD17B2SLC6A2SLC6A4SLC6A3
SCHEMBL20737738 0.85 PDK2 (0.46) HSD17B1HSD17B2PDK2CYP17A1CYP19A1
SCHEMBL20737736 0.84 PDK2 (0.39) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL20737735 0.84 CYP1A1 (0.41) PDK2PIM1MAOBCYP1A2
SCHEMBL20736576 0.84 PDK2 (0.38) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL20737731 0.83 PDK2 (0.38) HSD17B1HSD17B2PDK2
SCHEMBL20736570 0.83 MEN1 (0.40) HSD17B1HSD17B2PDK2MAOB
SCHEMBL20736574 0.83 MEN1 (0.40) HSD17B1HSD17B2PDK2PIM1MAOB
SCHEMBL20737692 0.83 PDK2 (0.34) HSD17B1HSD17B2PDK2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473315-B2 Polycyclic aromatic compound KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-11-18 US disclosed
US-20250081847-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-03-06 US disclosed
US-20200144513-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2020-05-07 US disclosed
US-20200144515-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2020-05-07 US disclosed
US-20200144514-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2020-05-07 US disclosed
US-10374166-B2 Polycyclic aromatic compound KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2019-08-06 US disclosed
EP-3345911-A1 POLYCYCLIC AROMATIC COMPOUNDS AND THEIR USE AS ORGANIC DEVICE MATERIAL Kwansei Gakuin Educational Foundation (JP) 2018-07-11 EP disclosed
EP-3109253-A1 POLYCYCLIC AROMATIC COMPOUND Kwansei Gakuin Educational Foundation (JP) 2016-12-28 EP disclosed
US-20150236274-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236274-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885
US-20250081847-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885
US-20200144514-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885
US-12473315-B2 Polycyclic aromatic compound PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885
US-20200144513-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885
US-20200144515-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885
US-10374166-B2 Polycyclic aromatic compound PAH, ALK, AOC2 HSD17B1 4141/4885HSD17B2 3405/4885SLC6A2 1011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.